Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Mometasone furoate for radiation dermatitis in breast cancer
NCT00438659Phase 3Completed
- Sponsor
- North Central Cancer Treatment Group
- Start
- Aug 2007
- Primary completion
- Jan 2010
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 3 trial of mometasone in radiation dermatitis, sponsored by North Central Cancer Treatment Group. Started Aug 2007; status: completed.
02
Drugs
mometasone
03
Conditions
radiation dermatitis
Beyond the preview
Go deeper on NCT00438659.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00438659.